BioCryst Pharmaceuticals Inc
Closed
SectorHealthcare
9.94 -1.49
Overview
Share price change
24h
Min
9.91
Max
9.99
Income | 800M 78M |
|---|---|
Sales | 62M 218M |
P/E Sector Avg | 7.603 56.659 |
EPS | 0.3 |
Profit margin | 35.92 |
Employees | 435 |
EBITDA | 799M 99M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +105.22% upside |
Next Earnings | 2 Nov 2026 |
|---|
Market Cap | 240M 2.5B |
|---|---|
Previous open | 11.43 |
Previous close | 9.94 |
News Sentiment
By Acuity
81%
19%
317 / 339 Healthcare
BioCryst Pharmaceuticals Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
BioCryst Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 20.44 USD 105.22%
High 32 USD
Low 12 USD
Based on 9 Wall Street analysts offering 12 month price targets forBioCryst Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$